Journal for ImmunoTherapy of Cancer (Oct 2021)

Multicenter, double-blind, placebo-controlled trial of seviprotimut-L polyvalent melanoma vaccine in patients with post-resection melanoma at high risk of recurrence

  • Omid Hamid,
  • Brendan Curti,
  • Craig L Slingluff,
  • Mohammed Milhem,
  • Jose Lutzky,
  • Suthee Rapisuwon,
  • Brian Gastman,
  • Takami Sato,
  • Marcus O Butler,
  • Robert Andtbacka,
  • Eddy Hsueh,
  • Robert Weber,
  • John Glaspy,
  • Sekwon Jang,
  • Sajeve Thomas,
  • Karl D Lewis,
  • Leonel Hernandez-Aya,
  • John Hyngstrom,
  • Adam Berger,
  • Edward Levine,
  • Montaser F Shaheen,
  • Vinay Gupta,
  • Svetomir N Markovic,
  • Tawnya Bowles,
  • Joel Claveau,
  • Prejesh Philips,
  • Shernan G Holtan,
  • William Schmidt,
  • Juan Paramo,
  • Arvinda Padmanabhan,
  • Daniel Milton,
  • Andrew Pecora,
  • Suprith Badarinath,
  • John Keech,
  • Sujith Kalmadi,
  • Pallavi Kumar,
  • Anna Bar,
  • J Thaddeus Beck,
  • Jeffrey B Travers,
  • Catalin Mihalcioiu,
  • Peter Beitsch,
  • Edward C McCarron,
  • Deepti Behl,
  • Brent Blumenstein,
  • Joanna J Peterkin

DOI
https://doi.org/10.1136/jitc-2021-003272
Journal volume & issue
Vol. 9, no. 10

Abstract

Read online

No abstracts available.